Birkenstock's Growth Narrative Intact, but Valuation and Governance Risks Keep Deep Value on Hold

What happened

A new Seeking Alpha article rates Birkenstock as a Strong Buy with 21% upside to €36.5 per share, citing robust brand equity and growth prospects driven by closed-toe scaling and APAC expansion. The article highlights Q3 results showing 13% YoY revenue growth, strong D2C momentum, APAC outperformance, and management raising full-year guidance. However, the latest DeepValue master report maintains a WAIT stance as of December 2025, noting shares trade at ~24x TTM EPS and ~17x EV/EBITDA, about 80% above a conservative DCF reference. The master report also flags persistent material weaknesses in internal controls, new U.S. tariffs on EU-made product, and a leveraged balance sheet with TRA obligations. While the new article underscores positive fundamentals already known, it does not address the valuation disconnect or governance concerns that underpin the WAIT judgment.

Implication

The bullish article reinforces Birkenstock's strong brand and growth execution, but the market already prices in continued double-digit growth at 24x earnings, leaving little room for error. Tariff and FX headwinds, along with unresolved internal-control issues, could pressure margins and sentiment, making the current risk/reward unattractive for value investors. A pullback toward the mid-teens P/E or evidence of successful tariff mitigation and control remediation would warrant a more constructive view. Conversely, any signs of brand fatigue, margin compression, or governance setbacks would confirm the downside risks outlined in the master report. For now, the prudent stance is to wait for a larger margin of safety or clearer catalysts.

Thesis delta

The new Seeking Alpha article does not shift the DeepValue thesis from WAIT to BUY, as its bullish arguments largely reiterate known strengths without addressing the valuation gap and structural risks. The article's target price implies upside but is based on a less conservative framework; the master report's DCF indicates significant overvaluation. No new fundamental data or risk mitigation is presented, so the WAIT stance remains appropriate.